Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of obesity drug therapy.

Current molecular medicine - 1 Jan 2014

Guzman A K, Ding M, Xie Y, Martin K A

Abstract excerpt

As the prevalence and severity of obesity and its complications have risen significantly in worldwide populations, behavioral interventions alone have been inconsistent in promoting sufficient, sustained weight loss. Consequently, there has been intense interest in the development of anti-obesity medications as treatment strategies. When coupled with structured lifestyle modifications, pharmacotherapy can enhance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genome-Wide Association Study
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Obesity

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Risk Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 25109792
DOI: 10.2174/1566524014666140811120307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of obesity drug therapy.PMID 25109792Read ↗

Pharmacogenomics of Anti-Obesity Drugs: A Bioinformatics ApproachSemantic proximity Read ↗

Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical PracticeSemantic proximity Read ↗

Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical Practice.Semantic proximity Read ↗

Pharmacogenetics of addiction therapy.Semantic proximity Read ↗

Genetic risk, antiseizure medications, and lifestyle factors in epilepsy-associated obesity and overweight.Semantic proximity Read ↗

Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity ClinicSemantic proximity Read ↗

CLINICAL CHARACTERISTICS OF USERS OF WEIGHT LOSS DRUGS: POPULATION-BASED CASE-CONTROL STUDYSemantic proximity Read ↗

A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults.Semantic proximity Read ↗

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.Semantic proximity Read ↗

Weight gain with antipsychotic drugs: the role of the 5-HT2C receptor (HTR2C) and other genes.Semantic proximity Read ↗

Weight change, genetics and antiepileptic drugs.Semantic proximity Read ↗

Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.